CHRONIC HEPATITIS B INFECTION
Clinical trials for CHRONIC HEPATITIS B INFECTION explained in plain language.
Never miss a new study
Get alerted when new CHRONIC HEPATITIS B INFECTION trials appear
Sign up with your email to follow new studies for CHRONIC HEPATITIS B INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill challenges standard hepatitis b treatment in major trial
Disease control Recruiting nowThis study is testing if a new daily pill, ALG-000184, is better than the standard drug tenofovir at controlling the Hepatitis B virus. It will involve about 200 adults with chronic Hepatitis B who are not currently on treatment. Participants will take one of the two pills for 48…
Matched conditions: CHRONIC HEPATITIS B INFECTION
Phase: PHASE2 • Sponsor: Aligos Therapeutics • Aim: Disease control
Last updated Apr 02, 2026 08:56 UTC
-
First safety check for hepatitis b drug in vulnerable kidney patients
Disease control Recruiting nowThis early-stage study is checking how a new hepatitis B drug, pevifoscorvir sodium, is processed by the body in people with reduced kidney function. Researchers will give a single dose to about 30 participants—some with kidney impairment and some with healthy kidneys—and closely…
Matched conditions: CHRONIC HEPATITIS B INFECTION
Phase: PHASE1 • Sponsor: Aligos Therapeutics • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC